UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 7 Issue 5
June-2020
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2005400


Registration ID:
233678

Page Number

635-642

Share This Article


Jetir RMS

Title

Siddha Medicine Combat Against Novel Corona Virus – An Appraisal.

Abstract

Introduction: Infectious viral diseases kill seventeen million and over people annually. Nature based pharmacotherapy tends to be an alternate to antivirals in circumstance of inadequate effectiveness and antagonistic. Consequently, various Siddha herbal and metalloids pharmaceutical have been in use for therapeutic resolutions since olden eras and are recognized for our antiviral possessions with durable aftereffect. Specified the challenges and possibilities of Siddha Medicine’s antiviral treatment towards the current COVID - 19, this analysis emphases the substantiated data on herbal and metalliod substances as these assorted knowhows can offer effective and unfailing delivery. Data source: The data used were obtained from PubMed, Google Scholar, ScienceDirect etc. Terms of Siddha herbs, metalloids and COVID – 19 infections were used as search. Result: Infectious COVID -19 is causing utmost demise all round the world. As a customary medicine, deliberately Siddha Phyto herbal and metalloid compositions supports the positive clinical findings therewith of Novel Corona virus and three kind of tāenta curaṅkaḷ (varied fevers) which are widely proved effective in practice. The administration of Siddha drugs inclines to regulates immune activity, providing synergistic advantage on preventing and curing pathogen, could be thereupon of Novel Corona virus also. The remarkable delivery systems including decoction, nanoparticles in Siddha Medicine are an added gain. Conclusion: Siddha formulations, on emergence of latest viral variants could inhibit pathogens or synchronize the immune to sack out infections, and henceforth should be explored and analysed sooner as they stretch sturdy mark to defend life.

Key Words

Antiviral, COVID – 19, Siddha formulations

Cite This Article

"Siddha Medicine Combat Against Novel Corona Virus – An Appraisal.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 5, page no.635-642, June-2020, Available :http://www.jetir.org/papers/JETIR2005400.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Siddha Medicine Combat Against Novel Corona Virus – An Appraisal.", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 5, page no. pp635-642, June-2020, Available at : http://www.jetir.org/papers/JETIR2005400.pdf

Publication Details

Published Paper ID: JETIR2005400
Registration ID: 233678
Published In: Volume 7 | Issue 5 | Year June-2020
DOI (Digital Object Identifier):
Page No: 635-642
Country: Tirunelveli, Tamil Nadu, India .
Area: Medical Science
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

0002975

Print This Page

Current Call For Paper

Jetir RMS